Conavi Medical Corp. (TSXV:CNVI)

Revenue by Segment

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
Development and Commercialization of Imaging Technologies	9.12M	2.16M	2.36M	2.70M
Development and Commercialization of Imaging Technologies Growth	322.12%	-8.59%	-12.44%	-
Total	9.12M	2.16M	2.36M	2.70M
Total Growth	322.12%	-8.59%	-12.44%	-

Revenue by Geography

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022
North America (Excluding Canada)	5.00K	84.00K	46.00K	83.00K
North America (Excluding Canada) Growth	-94.05%	82.61%	-44.58%	-
Asia	9.12M	2.07M	2.29M	2.58M
Asia Growth	339.80%	-9.52%	-11.24%	-
Canada	-	4.00K	27.00K	36.00K
Canada Growth	-	-85.19%	-25.00%	-
Total	9.12M	2.16M	2.36M	2.70M
Total Growth	322.12%	-8.59%	-12.44%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 13, 2026

Data Sources Report a data error